Caseware UK (AP4) 2024.0.164 2024.0.164 2024-12-312024-12-312The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.2024-01-01falseNo description of principal activity2falsetruefalse SC650223 2024-01-01 2024-12-31 SC650223 2023-01-01 2023-12-31 SC650223 2024-12-31 SC650223 2023-12-31 SC650223 c:Director1 2024-01-01 2024-12-31 SC650223 c:Director2 2024-01-01 2024-12-31 SC650223 c:RegisteredOffice 2024-01-01 2024-12-31 SC650223 d:OfficeEquipment 2024-01-01 2024-12-31 SC650223 d:OfficeEquipment 2024-12-31 SC650223 d:OfficeEquipment 2023-12-31 SC650223 d:OfficeEquipment d:LeasedAssetsHeldAsLessee 2024-01-01 2024-12-31 SC650223 d:CurrentFinancialInstruments 2024-12-31 SC650223 d:CurrentFinancialInstruments 2023-12-31 SC650223 d:CurrentFinancialInstruments d:WithinOneYear 2024-12-31 SC650223 d:CurrentFinancialInstruments d:WithinOneYear 2023-12-31 SC650223 d:ShareCapital 2024-12-31 SC650223 d:ShareCapital 2023-12-31 SC650223 d:RetainedEarningsAccumulatedLosses 2024-12-31 SC650223 d:RetainedEarningsAccumulatedLosses 2023-12-31 SC650223 c:OrdinaryShareClass1 2024-01-01 2024-12-31 SC650223 c:OrdinaryShareClass1 2024-12-31 SC650223 c:OrdinaryShareClass1 2023-12-31 SC650223 c:FRS102 2024-01-01 2024-12-31 SC650223 c:AuditExempt-NoAccountantsReport 2024-01-01 2024-12-31 SC650223 c:FullAccounts 2024-01-01 2024-12-31 SC650223 c:PrivateLimitedCompanyLtd 2024-01-01 2024-12-31 SC650223 e:PoundSterling 2024-01-01 2024-12-31 xbrli:shares iso4217:GBP xbrli:pure
Registered number: SC650223










TARTAN CELL TECHNOLOGIES LIMITED
FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024

 
TARTAN CELL TECHNOLOGIES LIMITED
 

COMPANY INFORMATION


Directors
Prof. A Lamond 
Prof. J Swedlow 




Registered number
SC650223



Registered office
Unit 14
City Quay

Dundee

DD1 3JA





 
TARTAN CELL TECHNOLOGIES LIMITED
REGISTERED NUMBER: SC650223

STATEMENT OF FINANCIAL POSITION
AS AT 31 DECEMBER 2024

2024
2023
£
£

FIXED ASSETS
  

Tangible assets
 4 
1
336

  
1
336

CURRENT ASSETS
  

Debtors: amounts falling due within one year
 5 
2,371
1,549

Cash at bank and in hand
  
24,028
47,069

  
26,399
48,618

Creditors: amounts falling due within one year
 6 
(3,215)
(20,242)

NET CURRENT ASSETS
  
 
 
23,184
 
 
28,376

TOTAL ASSETS LESS CURRENT LIABILITIES
  
23,185
28,712

  

NET ASSETS
  
23,185
28,712


CAPITAL AND RESERVES
  

Called up share capital 
 7 
100
100

Profit and loss account
  
23,085
28,612

  
23,185
28,712


Page 1

 
TARTAN CELL TECHNOLOGIES LIMITED
REGISTERED NUMBER: SC650223

STATEMENT OF FINANCIAL POSITION (CONTINUED)
AS AT 31 DECEMBER 2024

The directors consider that the Company is entitled to exemption from audit under section 477 of the Companies Act 2006 and members have not required the Company to obtain an audit for the year in question in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and in accordance with the provisions of FRS 102 Section 1A - small entities.

The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The Company has opted not to file the statement of income and retained earnings in accordance with provisions applicable to companies subject to the small companies' regime.

The financial statements were approved and authorised for issue by the board and were signed on its behalf on 26 September 2025.




Prof. J Swedlow
Director

The notes on pages 3 to 6 form part of these financial statements.

Page 2

 
TARTAN CELL TECHNOLOGIES LIMITED
 

 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024

1.


GENERAL INFORMATION

Tartan Cell Technologies Limited is a private company, limited by shares, domiciled in Scotland with registration number SC650223. The registered office is Unit 14, City Quay, Dundee, DD1 3JA. The trading address is 18a Rockfield Street, Dundee, DD2 1LD.

2.ACCOUNTING POLICIES

 
2.1

BASIS OF PREPARATION OF FINANCIAL STATEMENTS

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with FRS 102 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland' and the requirements of the Companies Act 2006. The disclosure requirements of Section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The following principal accounting policies have been applied:

 
2.2

TURNOVER

Turnover is recognised to the extent that it is probable that the economic benefits will flow to the Company and the turnover can be reliably measured. Turnover is measured as the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes. The following criteria must also be met before turnover is recognised:

Rendering of services

Turnover from a contract to provide services is recognised in the period in which the services are provided in accordance with the stage of completion of the contract when all of the following conditions are satisfied:
the amount of turnover can be measured reliably;
it is probable that the Company will receive the consideration due under the contract;
the stage of completion of the contract at the end of the reporting period can be measured reliably; and
the costs incurred and the costs to complete the contract can be measured reliably.

Page 3

 
TARTAN CELL TECHNOLOGIES LIMITED
 

 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024

2.ACCOUNTING POLICIES (CONTINUED)

 
2.3

TANGIBLE FIXED ASSETS

Tangible fixed assets under the cost model are stated at historical cost less accumulated depreciation and any accumulated impairment losses. Historical cost includes expenditure that is directly attributable to bringing the asset to the location and condition necessary for it to be capable of operating in the manner intended by management.

Depreciation is charged so as to allocate the cost of assets less their residual value over their estimated useful lives, using the straight-line method.

Depreciation is provided on the following basis:

Office equipment
-
25%

The assets' residual values, useful lives and depreciation methods are reviewed, and adjusted prospectively if appropriate, or if there is an indication of a significant change since the last reporting date.

Gains and losses on disposals are determined by comparing the proceeds with the carrying amount and are recognised in profit or loss.


3.


EMPLOYEES

The average monthly number of employees, including directors, during the year was 2 (2023 - 2).






Page 4

 
TARTAN CELL TECHNOLOGIES LIMITED
 

 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024

4.


TANGIBLE FIXED ASSETS





Office equipment

£



COST OR VALUATION


At 1 January 2024
1,341



At 31 December 2024

1,341



DEPRECIATION


At 1 January 2024
1,005


Charge for the year on financed assets
335



At 31 December 2024

1,340



NET BOOK VALUE



At 31 December 2024
1



At 31 December 2023
336


5.


DEBTORS

2024
2023
£
£


Other debtors
1,356
534

Prepayments and accrued income
1,015
1,015

2,371
1,549



6.


CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

2024
2023
£
£

Trade creditors
900
11,426

Other creditors
-
6,632

Accruals and deferred income
2,315
2,184

3,215
20,242


Page 5

 
TARTAN CELL TECHNOLOGIES LIMITED
 

 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024

7.


SHARE CAPITAL

2024
2023
£
£
ALLOTTED, CALLED UP AND FULLY PAID



100 (2023 - 100) Ordinary shares of £1.00 each
100
100



Page 6